BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23016772)

  • 1. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy.
    Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
    PLoS One; 2011; 6(10):e26022. PubMed ID: 21998748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    PLoS One; 2014; 9(11):e112934. PubMed ID: 25405981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology.
    Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
    PLoS One; 2011; 6(8):e24083. PubMed ID: 21918682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing.
    Sørbye SW; Fismen S; Gutteberg T; Mortensen ES
    PLoS One; 2010 Sep; 5(9):e12724. PubMed ID: 20856930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
    J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
    Rijkaart DC; Heideman DA; Coupe VM; Brink AA; Verheijen RH; Skomedal H; Karlsen F; Morland E; Snijders PJ; Meijer CJ
    J Clin Microbiol; 2012 Jul; 50(7):2390-6. PubMed ID: 22553244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme.
    Nygård M; Røysland K; Campbell S; Dillner J
    BMJ Open; 2014 Jan; 4(1):e003460. PubMed ID: 24401720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Possibly Oncogenic High-Risk Human Papillomavirus (HPV) Types in Triage for ASC-US Cervical Cytology Results.
    Amarosa EJ; Winer RL; Hong KJ; Mao C
    J Low Genit Tract Dis; 2015 Oct; 19(4):307-10. PubMed ID: 26125096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
    Zhang SK; Zhao DM; Chen HM; Guo Z; Ren LY; Jia MM; Chang JJ; Chen PP; Liu SZ; Sun XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):941-945. PubMed ID: 30196643
    [No Abstract]   [Full Text] [Related]  

  • 14. The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China.
    Pan D; Dong B; Gao H; Mao X; Xue H; Sun P
    Risk Manag Healthc Policy; 2020; 13():1747-1756. PubMed ID: 33061708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
    McKenna M; McMenamin MM
    Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening.
    Fröberg M; Norman I; Johansson B; Hjerpe A; Weiderpass E; Andersson S
    Curr Pharm Des; 2013; 19(8):1406-11. PubMed ID: 23016773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus DNA and E6/E7 mRNA testing as triage in liquid-based cytology samples from primary screening.
    Andersson S; Mints M; Weiderpass E; Johansson B
    Curr Pharm Des; 2013; 19(8):1508-15. PubMed ID: 23072430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
    Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
    J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.
    Westre B; Giske A; Guttormsen H; Sørbye SW; Skjeldestad FE
    BMC Clin Pathol; 2016; 16():9. PubMed ID: 27279798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.